If patients can understand the potential risks and benefits of each test, then I think they are more likely to accept fewer tests.
Chunkit Fung, MD, MSCE
Co-Chair and moderator of the session, Chunkit Fung, MD, MSCE, Assistant Professor at the Wilmot Cancer Center of the University of Rochester in New York, underscored the issue of oversurveillance and patients’ reluctance to adopt a less-is-more philosophy of health care.
“Talking to patients about the rationale behind cancer screenings is vital,” Dr. Fung explained. “If patients can understand the potential risks and benefits of each test, then I think they are more likely to accept fewer tests.”
He continued, “I also think it’s important to understand the goals of patient-centered care in order to personalize our screening procedures. Just spending time with the patient is the most important thing you can do.” ■
Disclosure: Dr. Fung reported no potential conflicts of interest.
Striking the right balance between under- and oversurveillance of cancer survivors is challenging, and oncology providers are best served by knowing and following guidelines—though they can change often.
Cancer recurrence and second cancers are two of the major threats to the health of cancer...